Moderna
MRNA
#1217
Rank
C$22.03 B
Marketcap
$57.25
Share price
-3.95%
Change (1 day)
-57.83%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$5.62 Billion

According to Moderna 's latest financial reports the company's total liabilities are C$5.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$6.06 B-33.65%
2022-12-31C$9.13 B-31.86%
2021-12-31C$13.41 B120.24%
2020-12-31C$6.08 B1024.59%
2019-12-31C$0.54 B-7.96%
2018-12-31C$0.58 B1.91%
2017-12-31C$0.57 B-25.33%
2016-12-31C$0.77 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$10.1 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
C$105.98 B 1,782.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$63.64 M-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.06 B 7.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$87.26 B 1,450.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$1.37 B-75.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$157.04 B 2,689.71%๐Ÿ‡บ๐Ÿ‡ธ USA